Unresectable vs. Resectable Thyroid Cancer (Pt. 1)

What makes a thyroid tumor truly unresectable? In this episode, Dr. Dana Hartl speaks with Dr. Mark Zafereo about how molecular testing and targeted neoadjuvant therapies are redefining surgical eligibility for patients with anaplastic thyroid cancer. Listen in as they explore the evolving role of BRAF/MEK inhibitors, imaging strategies, and real-world decision-making in complex cases.

• Likes
• Download118
• Share